Showing results (111-120 of 190) with videos related to

Sort By:
Pageof 19
Medical Oncology (Northwood, London, England)|June 26, 2012
Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17)Peter H Wiernik, Zhuoxin Sun, Holly Gundacker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2019
Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell CarcinomaWenxin Xu, Maneka Puligandla, Judith Manola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2007
Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemiasDejan Juric, Norman J Lacayo, Meghan C Ramsey, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registryBrendan Curti, Gregory A Daniels, David F McDermott, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2010
A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphomaOmer N Koç, Charles Redfern, Peter H Wiernik, et al.
Blood|March 27, 2004
Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemiasElisabeth Paietta, Adolfo A Ferrando, Donna Neuberg, et al.
British Journal of Haematology|June 19, 2021
Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemiaPeter H Wiernik, Zhuoxin Sun, Larry D Cripe, et al.
Lancet (London, England)|February 21, 2004
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemiaAdolfo A Ferrando, Donna S Neuberg, Richard K Dodge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Phenotypic heterogeneity in multiple myeloma familiesHenry T Lynch, Patrice Watson, Stefano Tarantolo, et al.
Pageof 19